Matches in Nanopublications for { ?s ?p "[This review discusses recent advances in our understanding of the abnormal skin barrier in AD, namely abnormalities in epidermal structural proteins, such as filaggrin, mutated in approximately 15% of patients with AD, epidermal lipids, and epidermal proteases and protease inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[This review discusses recent advances in our understanding of the abnormal skin barrier in AD, namely abnormalities in epidermal structural proteins, such as filaggrin, mutated in approximately 15% of patients with AD, epidermal lipids, and epidermal proteases and protease inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This review discusses recent advances in our understanding of the abnormal skin barrier in AD, namely abnormalities in epidermal structural proteins, such as filaggrin, mutated in approximately 15% of patients with AD, epidermal lipids, and epidermal proteases and protease inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP741648.RAtzOujOfwFzTzKW9woO7YOmekkq4ZcpaBLY8fEKQbSLI130_assertion description "[This review discusses recent advances in our understanding of the abnormal skin barrier in AD, namely abnormalities in epidermal structural proteins, such as filaggrin, mutated in approximately 15% of patients with AD, epidermal lipids, and epidermal proteases and protease inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741648.RAtzOujOfwFzTzKW9woO7YOmekkq4ZcpaBLY8fEKQbSLI130_provenance.
- NP741646.RAF_UXshDw_buWzbhoXMcqDIifeq6uocs-6DpZ5-TfeTo130_assertion description "[This review discusses recent advances in our understanding of the abnormal skin barrier in AD, namely abnormalities in epidermal structural proteins, such as filaggrin, mutated in approximately 15% of patients with AD, epidermal lipids, and epidermal proteases and protease inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741646.RAF_UXshDw_buWzbhoXMcqDIifeq6uocs-6DpZ5-TfeTo130_provenance.